Is (2R*,6R*,11R*)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use (2R*,6R*,11R*)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol? Is (2R*,6R*,11R*)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol safe for nursing mother and child? Does (2R*,6R*,11R*)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol extracts into breast milk? Does (2R*,6R*,11R*)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol has any long term or short term side effects on infants? Can (2R*,6R*,11R*)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol influence milk supply or can (2R*,6R*,11R*)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol decrease milk supply in lactating mothers?
(2R*,6R*,11R*)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol lactation summary
- DrLact safety Score for (2R*,6R*,11R*)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol is 3 out of 8 which is considered Low Risk as per our analyses.
- A safety Score of 3 indicates that usage of (2R*,6R*,11R*)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol may cause some minor side effects in breastfed baby.
- Our study of different scientific research indicates that (2R*,6R*,11R*)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol may cause moderate to no side effects in lactating mother.
- Most of scientific studies and research papers declaring usage of (2R*,6R*,11R*)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- While using (2R*,6R*,11R*)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About (2R*,6R*,11R*)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol usage in lactation
We are working on a comment for this product.
Answer by DrLact: About (2R*,6R*,11R*)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol usage in lactation
No information is available on the use of (2R*,6R*,11R*)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol during breastfeeding. Maternal use of oral narcotics during breastfeeding can cause infant drowsiness, central nervous system depression and even death. Newborn infants seem to be particularly sensitive to the effects of even small dosages of narcotic analgesics. Once the mother's milk comes in, it is best to provide pain control with a nonnarcotic analgesic and limit maternal intake of (2R*,6R*,11R*)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol to a few days at a low dosage with close infant monitoring. If the baby shows signs of increased sleepiness (more than usual), difficulty breastfeeding, breathing difficulties, or limpness, a physician should be contacted immediately. Other agents are preferred over (2R*,6R*,11R*)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol during breastfeeding.[1]
(2R*,6R*,11R*)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol Possible Effects in Breastfeeding
(2R*,6R*,11R*)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol can increase serum prolactin.[2][3] However, the prolactin level in a mother with established lactation may not affect her ability to breastfeed.
Alternate Drugs
Morphine(Low Risk)
Remifentanil(Low Risk)
Butorphanol(Low Risk)
Methadone(Safe)
Propoxyphene(Safe)
Buprenorphine(Safe)
Meperidine(Low Risk)
Heroin(Dangerous)
Pentazocine(Low Risk)
Alfentanil(Safe)
Hydrocodone(Low Risk)
Oxycodone(Unsafe)
Tramadol(Safe)
Fentanyl(Safe)
Sufentanil(Low Risk)
Butorphanol(Low Risk)
Buprenorphine(Safe)
Pentazocine(Low Risk)
Naloxone(Low Risk)
Naltrexone(Low Risk)
Remifentanil(Low Risk)
Butorphanol(Low Risk)
Methadone(Safe)
Propoxyphene(Safe)
Buprenorphine(Safe)
Meperidine(Low Risk)
Heroin(Dangerous)
Pentazocine(Low Risk)
Alfentanil(Safe)
Dihydrocodeine(Low Risk)
Hydrocodone(Low Risk)
Oxycodone(Unsafe)
Tramadol(Safe)
Fentanyl(Safe)
Sufentanil(Low Risk)
Codeine(Unsafe)
Morphine(Low Risk)
Meperidine(Low Risk)
Pentazocine(Low Risk)
Oxycodone(Unsafe)
Fentanyl(Safe)
Sufentanil(Low Risk)
Butorphanol(Low Risk)
Remifentanil(Low Risk)